arrow
C

Christophe Moreno

autonomous university of barcelona
H指数:71
被引数:2.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Progression to cirrhosis in chronic hepatitis D with mild-to-moderate fibrosis: Insights from a multicenter European cohort (vol 8, 101898, 2026)

慢性丁型肝炎伴轻度至中度纤维化进展为肝硬化的进程:来自多中心欧洲队列的见解(卷8,101898,2026)

2026-09-010
OA
Hepatology: Emerging Paradigms in MASLD, Viral Hepatitis, Cholestatic Liver Disease, Portal Hypertension and Hepatocellular Carcinoma

肝病学:MASLD、病毒性肝炎、胆汁淤积性肝病、门静脉高压和肝细胞癌的新兴范式

2026-08-300
PRE
Progression to cirrhosis in chronic hepatitis D with mild-to-moderate fibrosis: insights from a multicenter European cohort.

慢性丁型肝炎伴轻度至中度纤维化进展为肝硬化的情况:来自一项多中心欧洲队列研究的见解

2026-05-190
OAAI
Clinical Trial: Hepatitis B Virus Genotype and a Combination of End-of-Treatment Biomarkers Predict Severe Flares After Nucleos(t)ide Analogue Cessation

临床试验:乙型肝炎病毒基因型和一组治疗结束生物标志物预测核苷(酸)类似物停药后的严重肝炎发作

2025-11-010
PRE
Co-existing regeneration mechanisms in severe alcohol-related steatohepatitis
2025-01-011
OAAI
Patient and physician expectations regarding disease and treatment of advanced HCC: The prospective PERCEPTION1 study
2024-11-010
OAAI
Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients

欧洲DAA经验患者的罕见HCV亚型和再治疗结果

2024-07-010
OAAI
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease

关于使用国际疾病分类代码治疗代谢功能障碍相关脂肪肝疾病的全球调查

2024-06-159
PRE
A polygenic risk score for alcohol-associated cirrhosis among heavy drinkers with European ancestry
2024-06-017
OAAI